Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson's disease: Contribution of automated segmentation neuroimaging method

Parkinsonism and Related Disorders

Volumn 18, Issue 5, 2012, Pages 562-566

  Bilgic, Basar ^a   Bayram, Ali ^b   Arslan, Ali Bilgin ^c   Hanagasi, Hasmet ^a   Dursun, Burcu ^d   Gurvit, Hakan ^a   Emre, Murat ^a   Lohmann, Ebba ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Istanbul Neuropsychiatry Hospital   (Turkey)

^c BROWN UNIVERSITY   (United States)

^d ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Automatic segmentation; MRI; Parkin gene; Parkinson's disease

Indexed keywords

LEVODOPA; PARKIN;

ARTICLE; AUTOMATIC SEGMENTATION METHOD; BASAL GANGLION; BRAIN CORTEX ATROPHY; BRAIN SIZE; BRAIN STEM; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; GENE PRODUCT; GENETIC ASSOCIATION; HUMAN; IMAGE PROCESSING; MALE; NEUROPSYCHIATRY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKIN GENE; PARKINSON DISEASE; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; AGED; ANALYSIS OF VARIANCE; BASAL GANGLIA; BRAIN MAPPING; COGNITION DISORDERS; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; UBIQUITIN-PROTEIN LIGASES; YOUNG ADULT;

EID: 84861185880     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.02.017     Document Type: Article

References (33)

1. Klein C., Schlossmacher M.G. Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder. Neurology 2007, 69:2093-2104.
2. Khan N.L., Graham E., Critchley P., Schrag A.E., Wood N.W., Lees A.J., et al. Parkin disease: a phenotypic study of a large case series. Brain 2003, 126:1279-1292.
3. Khan N.L., Brooks D.J., Pavese N., Sweeney M.G., Wood N.W., Lees A.J., et al. Progression of nigrostriatal dysfunction in a Parkin kindred: an [18F]dopa PET and clinical study. Brain 2002, 125:2248-2256.
4. Lohmann E., Thobois S., Lesage S., Broussolle E., Montcel ST du, Ribeiro M.-J., et al. A multidisciplinary study of patients with early-onset PD with and without Parkin mutations. Neurology 2009, 72:110-116.
5. Lohmann E., Periquet M., Bonifati V., Wood N.W., Michele G.De, Bonnet A.-M., et al. How much phenotypic variation can be attributed to Parkin genotype?. Ann Neurol 2003, 54:176-185.
6. Wu R.-M., Shan D.-E., Sun C.-M., Liu R.-S., Hwu W.-L., Tai C.-H., et al. Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and Parkin gene mutations. Mov Disord 2002, 17:670-675.
7. Yamamura Y., Hattori N., Matsumine H., Kuzuhara S., Mizuno Y. Autosomal recessive early-onset parkinsonism with diurnal fluctuation: clinicopathologic characteristics and molecular genetic identification. Brain Dev 2000, 22(Suppl. 1):87-91.
8. Lisanby S.H., McDonald W.M., Massey E.W., Doraiswamy P.M., Rozear M., Boyko O.B., et al. Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging. J Neural Transm 1993, 40:13-21.
9. Brenneis C., Seppi K., Schocke M.F., Müller J., Luginger E., Bösch S., et al. Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy. Mov Disord 2003, 18:1132-1138.
10. Krabbe K., Karlsborg M., Hansen A., Werdelin L., Mehlsen J., Larsson H.B.W., et al. Increased intracranial volume in Parkinson's disease. J Neurol Sci 2005, 239:45-52.
11. O'Neill J., Schuff N., Marks W.J., Feiwell R., Aminoff M.J., Weiner M.W. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease. Mov Disord 2002, 17:917-927.
12. Schulz J.B., Skalej M., Wedekind D., Luft A.R., Abele M., Voigt K., et al. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1999, 45:65-74.
13. Ghaemi M., Hilker R., Rudolf J., Sobesky J., Heiss W.-D. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J Neurol Neurosurg Psychiatr 2002, 73:517-523.
14. Reetz K., Gaser C., Klein C., Hagenah J., Büchel C., Gottschalk S., et al. Structural findings in the basal ganglia in genetically determined and idiopathic Parkinson's disease. Mov Disord 2009, 24:99-103.
15. Binkofski F., Reetz K., Gaser C., Hilker R., Hagenah J., Hedrich K., et al. Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia. Neurology 2007, 69:842-850.
16. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
17. Pengas G., Pereira J.M.S., Williams G.B., Nestor P.J. Comparative reliability of total intracranial volume estimation methods and the influence of atrophy in a longitudinal semantic dementia cohort. J Neuroimaging 2009, 19:37-46.
18. McDonald C.R., Hagler D.J., Ahmadi M.E., Tecoma E., Iragui V., Dale A.M., et al. Subcortical and cerebellar atrophy in mesial temporal lobe epilepsy revealed by automatic segmentation. Epilepsy Res 2008, 79:130-138.
19. McDonald C.R., Hagler D.J., Ahmadi M.E., Tecoma E., Iragui V., Gharapetian L., et al. Regional neocortical thinning in mesial temporal lobe epilepsy. Epilepsia 2008, 49:794-803.
20. Tae W.S., Kim S.S., Lee K.U., Nam E.-C., Kim K.W. Validation of hippocampal volumes measured using a manual method and two automated methods (FreeSurfer and IBASPM) in chronic major depressive disorder. Neuroradiology 2008, 50:569-581.
21. Cerasa A., Messina D., Nicoletti G., Novellino F., Lanza P., Condino F., et al. Cerebellar atrophy in essential tremor using an automated segmentation method. AJNR Am J Neuroradiol 2009, 30:1240-1243.
22. Walhovd K.B., Fjell A.M., Reinvang I., Lundervold A., Dale A.M., Eilertsen D.E., et al. Effects of age on volumes of cortex, white matter and subcortical structures. Neurobiol Aging 2005, 26:1261-1270.
23. Tinaz S., Courtney M.G., Stern C.E. Focal cortical and subcortical atrophy in early Parkinson's disease. Mov Disord 2011, 26:436-441.
24. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatr 1992, 55:181-184.
25. Reetz K., Tadic V., Kasten M., Brüggemann N., Schmidt A., Hagenah J., et al. Structural imaging in the presymptomatic stage of genetically determined parkinsonism. Neurobiol Dis 2010, 39:402-408.
26. Pavese N., Khan N.L., Scherfler C., Cohen L., Brooks D.J., Wood D.J., et al. Nigrostriatal dysfunction in homozygous and heterozygous Parkin gene carriers: an 18F-dopa PET progression study. Mov Disord 2009, 24:2260-2266.
27. Gallagher C.L., Oakes T.R., Johnson S.C., Chung M.K., Holden J.E., Bendlin B.B., et al. Rate of 6-[18F]fluorodopa uptake decline in striatal subregions in Parkinson's disease. Mov Disord 2011, 26:614-620.
28. van de Warrenburg B.P., Lammens M., Lücking C.B., Denèfle P., Wesseling P., Booij J., et al. Clinical and pathologic abnormalities in a family with parkinsonism and Parkin gene mutations. Neurology 2001, 56:555-557.
29. Wang C., Tan J.M., Ho M.W., Zaiden N., Wong S.H., Chew C.L., et al. Alterationsin the solubility and intracellular localization of Parkin by several familial Parkinson's disease-linked point mutations. J Neurochem 2005, 93:422-431.
30. Narendra D., Tanaka A., Suen D.F., Youle R.J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 2008, 183:795-803.
31. Vives-Bauza C., Przedborski S. Mitophagy: the latest problem for Parkinson's disease. Trends Mol Med 2011, 17:158-165.
32. Perez F.A., Palmiter R.D. Parkin-deficient mice are not a robust model of parkinsonism. Proc Natl Acad Sci U S A 2005, 102:2174-2179.
33. Von Coelln R., Thomas B., Savitt J.M., Lim K.L., Sasaki M., Hess E.J., et al. Loss of locus coeruleus neurons and reduced startle in Parkin null mice. Proc Natl Acad Sci U S A 2004, 101:10744-10749.